Epidemiology, tumor characteristics, and survival in patients with primary pancreatic lymphoma: A large population-based study using the SEER database
American Journal of Clinical Oncology May 01, 2019
Mukhija D, et al. - From the Surveillance, Epidemiology and End Results (SEER) database, patients with primary pancreatic lymphoma (PPL; an extranodal manifestation of non-Hodgkin lymphoma originating in the pancreas) were analyzed in order to provide better insight into the epidemiology, treatment, and outcomes of these patients. Overall, researchers included 835 patients (median age of 67 [2 to 98] years). In patients with PPL, they noted improved survival in correlation with younger age, white race, early stage, and initial treatment with chemotherapy.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries